Method for inducing direct transdifferentiation of umbilical cord mesenchymal stem cells into erythroblasts
A qualitative stem cell and transdifferentiation technology, applied in the field of stem cells, can solve the problems of limited quantity, difficulties in erythroblasts, low efficiency of directed differentiation, etc., and achieve the effect of sufficient sources and easy access
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0039] Attached below picture The specific embodiment of the present invention is described in detail:
[0040] Such as figure 1 As shown, a method for inducing mesenchymal stem cells to transdifferentiate into erythroblasts, comprising the following steps:
[0041] S1, isolating and purifying homogeneous umbilical cord mesenchymal stem cells;
[0042] S2, selecting small RNA molecules that can be used for stem cell epigenetic regulation;
[0043] S3, preparation of small nucleic acid polypeptide nanoparticles and cell transfection;
[0044] S4, expansion and culture of erythroblasts after transfection.
[0045] Wherein, a chemotactic fluid is added in step S1, and the chemotactic fluid refers to the chemotactic SDF-SDF- 1 / CXCL12, HGF, EGF, bFGF, PDGF-BB and IGF-1 six chemokines.
[0046] The small RNA molecules described in step S2 are multiple, and the multiple small RNA molecules include sequences of ANTI-181b, ANTI-155, ANTI-10b, ANTI-24, ANTI-221 and siR-EID3 molec...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com